Zelnorm (tegaserod), a new drug for irritable bowel syndrome

September 2002

Novartis is now marketing Zelnorm (tegaserod), a new drug for irritable bowel syndrome.

Zelnorm is the first in a new class...5-HT4 serotonin partial agonist. It STIMULATES bowel motility to reduce abdominal pain...bloating...and constipation. It's for CONSTIPATION-predominant IBS.

This is different from Lotronex, which is a 5-HT3 serotonin antagonist that SLOWS bowel motility...for DIARRHEA-predominant IBS.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

People are asking how to prevent West Nile virus
Cardiology ACE inhibitors SHOULD be used in black patients with heart failure
Cardiology Diovan is now the first angiotensin receptor blocker APPROVED for heart failure
Cardiology statins used to prevent KIDNEY problems in patients with hypertension
drug interactions with grapefruit
Forest is launching its new SSRI antidepressant, Lexapro
treating pathological gamblers with drugs
date-rape" drugs, GHB, for patients with narcolepsy
Stroke Aspirin is in, anticoagulants are out for acute ISCHEMIC stroke
Pediatrics Neon Nits, a new topical spray to help locate lice eggs
Women's Health The marketing blitz is on for women's supplements
Mucinex is now the first 600 mg guaifenesin tab available OTC
Infectious Diseases first generic amoxicillin/clavulanate tabs and suspension
Hematology & Oncology which women might benefit from using tamoxifen to PREVENT breast cancer
Gastroenterology Zelnorm (tegaserod), a new drug for irritable bowel syndrome
Practice HIPAA privacy rules

Zelnorm (tegaserod), a new drug for irritable bowel syndrome

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents